Le Lézard
Classified in: Health
Subjects: WOM, MAT

VCF® female contraceptives is offering Free Samples to combat Roe v. Wade Decision by SCOTUS


VCF® brand of OTC female contraceptives underscores the importance of contraceptive solutions that champion women in the wake of Roe v. Wade.

NEW YORK, July 12, 2022 /PRNewswire/ -- With the Supreme Court's decision to overturn Roe v. Wade, VCF continues to stand by its mission to provide holistic contraceptive products that prioritize women's health.

VCF brand of contraceptives underscores the importance of contraceptive solutions that champion women in the wake of Roe

The landmark ruling has marked a profound change in society, bringing to light the importance of reproductive choice and the need for more women-controlled options to prevent unwanted pregnancy. For decades, VCF® has advocated for holistic health with VCF® Vaginal Contraceptive Film® and VCF® Contraceptive Gel as the only non-hormonal over-the-counter line of contraceptive products in a market which has, historically, left many of these options in the hands of men, essentially depriving women of rightful control and autonomy of their own bodies.

VCF®upholds its commitment to support women's rights to choose confidence and intimacy without fear of repercussions. VCF® Contraceptive Film® and VCF® Contraceptive Gel are safe, effective, and trusted contraceptive products that place women's health and right to choose front and center.

With limited access and even fewer options for non-hormonal birth control, VCF® remains a trusted contraceptive option for women that is reimbursable under the Affordable Care Act and can be immediately purchased at over 30,000 stores nationwide. For women with declining options, VCF® is offering free samples, available through its website vcfsample.com.

 About VCF®

VCF® products are manufactured by Apothecus Pharmaceutical Corp., a leader in personal intimacy products for over three decades. Apothecus brands are driven by innovation, taking pride in the quality of products that its dedicated team of professionals produces, The unique delivery systems its products utilize are of the highest quality, allowing for a revolutionary approach to film technology advancements that provide vital products for women's health. Learn more on the VCF website, or send an email to [email protected].

SOURCE VCF


These press releases may also interest you

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...



News published on and distributed by: